Cantargia receives Notice of Allowance in the US for the CAN04 patent application
The United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Cantargia AB’s (“Cantargia”) patent application for its CAN04 product candidate, which means that the USPTO intends to approve the company’s application. Cantargia has previously received an intention to grant notification for CAN04 in Europe.The patent application, no. 15/255,585, for which the USPTO has granted Notice of Allowance refers to the company’s CAN04 product candidate. The patent protects Cantargia’s product candidate, the CAN04 antibody, which is targeted against the IL1RAP target